{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:35:28Z","timestamp":1768354528986,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Luo Yuankai-Zishen Yutaiwan-Research Fund for Young Scholars","award":["20190810"],"award-info":[{"award-number":["20190810"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82174429"],"award-info":[{"award-number":["82174429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atosiban was commonly added to improve pregnancy outcomes of patients with repeated embryo implantation failure (RIF). In this study, we aimed to investigate the effect of atosiban before transferring the frozen-thawed embryo to RIF patients. This retrospective study was conducted in the Hospital for Reproductive Medicine affiliated to\u00a0Shandong University from August 2017 to June 2021. A total of 1774 women with a history of RIF undergoing frozen embryo transfer (FET) were included in this study. All the participants were classified into atosiban or control group: Group A included 677 patients who were administered atosiban intravenously 30\u00a0min prior to FET with a dose of 37.5\u00a0mg; Group B included 1097 patients who received no atosiban before the transfer. There were no significant differences observed in the live birth rate (LBR) (39.73% vs. 39.02%, <jats:italic>P<\/jats:italic>\u2009=\u20090.928) between the two groups. Other secondary outcomes including biochemical pregnancy rate, clinical pregnancy rate, implantation rate, clinical miscarriage rate and preterm birth rate were similar between the two groups (all <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). However, subgroup analysis demonstrated significantly higher preterm birth rates in the control group compared with the atosiban group (0 versus 3.0%, <jats:italic>P<\/jats:italic>\u2009=\u20090.024) in the natural FET cycles. Atosiban may not improve pregnancy outcomes of RIF patients in FET cycles. However, the effects of Atosiban on pregnancy outcomes should be assessed in clinical trials with larger sample sizes.<\/jats:p>","DOI":"10.1038\/s41598-023-36286-y","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T14:01:59Z","timestamp":1686146519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of atosiban for repeated implantation failure in frozen embryo transfer cycles"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiufang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbo","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huidan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"36286_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10815-014-0391-0","volume":"32","author":"M Roque","year":"2015","unstructured":"Roque, M. Freeze-all policy: is it time for that?. J. Assist. Reprod. Genet. 32, 171\u2013176. https:\/\/doi.org\/10.1007\/s10815-014-0391-0 (2015).","journal-title":"J. Assist. Reprod. Genet."},{"key":"36286_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.rbmo.2013.12.006","volume":"28","author":"LT Polanski","year":"2014","unstructured":"Polanski, L. T. et al. What exactly do we mean by \u201crecurrent implantation failure\u201d? A systematic review and opinion. Reprod. Biomed. Online 28, 409\u2013423. https:\/\/doi.org\/10.1016\/j.rbmo.2013.12.006 (2014).","journal-title":"Reprod. Biomed. Online"},{"key":"36286_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rbmo.2019.10.014","volume":"40","author":"A Busnelli","year":"2020","unstructured":"Busnelli, A. et al. How common is real repeated implantation failure? An indirect estimate of the prevalence. Reprod. Biomed. Online 40, 91\u201397. https:\/\/doi.org\/10.1016\/j.rbmo.2019.10.014 (2020).","journal-title":"Reprod. Biomed. Online"},{"key":"36286_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/gco.0000000000000620","volume":"32","author":"Y Cakiroglu","year":"2020","unstructured":"Cakiroglu, Y. & Tiras, B. Determining diagnostic criteria and cause of recurrent implantation failure. Curr. Opin. Obstet. Gynecol. 32, 198\u2013204. https:\/\/doi.org\/10.1097\/gco.0000000000000620 (2020).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"36286_CR5","doi-asserted-by":"publisher","first-page":"103121","DOI":"10.1016\/j.jri.2020.103121","volume":"139","author":"G Sheikhansari","year":"2020","unstructured":"Sheikhansari, G., Pourmoghadam, Z., Danaii, S., Mehdizadeh, A. & Yousefi, M. Etiology and management of recurrent implantation failure: A focus on intra-uterine PBMC-therapy for RIF. J. Reprod. Immunol. 139, 103121. https:\/\/doi.org\/10.1016\/j.jri.2020.103121 (2020).","journal-title":"J. Reprod. Immunol."},{"key":"36286_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810082","author":"AE Mrozikiewicz","year":"2021","unstructured":"Mrozikiewicz, A. E., O\u017carowski, M. & J\u0119drzejczak, P. Biomolecular markers of recurrent implantation failure-a review. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms221810082 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"36286_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/s0015-0282(01)02731-5","volume":"76","author":"WB Schoolcraft","year":"2001","unstructured":"Schoolcraft, W. B., Surrey, E. S. & Gardner, D. K. Embryo transfer: techniques and variables affecting success. Fertil. Steril. 76, 863\u2013870. https:\/\/doi.org\/10.1016\/s0015-0282(01)02731-5 (2001).","journal-title":"Fertil. Steril."},{"key":"36286_CR8","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/humrep\/13.7.1968","volume":"13","author":"R Fanchin","year":"1998","unstructured":"Fanchin, R. et al. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum. Reprod. 13, 1968\u20131974. https:\/\/doi.org\/10.1093\/humrep\/13.7.1968 (1998).","journal-title":"Hum. Reprod."},{"key":"36286_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12958-022-00999-y","volume":"20","author":"CL Tang","year":"2022","unstructured":"Tang, C. L. et al. A randomized double blind comparison of atosiban in patients with recurrent implantation failure undergoing IVF treatment. Reprod. Biol. Endocrinol. 20, 124. https:\/\/doi.org\/10.1186\/s12958-022-00999-y (2022).","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"Suppl 2","key":"36286_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s1472-6483(10)60450-6","volume":"18","author":"R Fanchin","year":"2009","unstructured":"Fanchin, R. & Ayoubi, J. M. Uterine dynamics: impact on the human reproduction process. Reprod. Biomed. Online 18(Suppl 2), 57\u201362. https:\/\/doi.org\/10.1016\/s1472-6483(10)60450-6 (2009).","journal-title":"Reprod. Biomed. Online"},{"key":"36286_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/humrep\/det429","volume":"29","author":"L Zhu","year":"2014","unstructured":"Zhu, L., Xiao, L., Che, H. S., Li, Y. P. & Liao, J. T. Uterine peristalsis exerts control over fluid migration after mock embryo transfer. Hum. Reprod. 29, 279\u2013285. https:\/\/doi.org\/10.1093\/humrep\/det429 (2014).","journal-title":"Hum. Reprod."},{"key":"36286_CR12","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/09513590.2016.1180680","volume":"32","author":"Y He","year":"2016","unstructured":"He, Y. et al. Application of atosiban in frozen-thawed cycle patients with different times of embryo transfers. Gynecol. Endocrinol. 32, 811\u2013815. https:\/\/doi.org\/10.1080\/09513590.2016.1180680 (2016).","journal-title":"Gynecol. Endocrinol."},{"key":"36286_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.rbmo.2012.05.014","volume":"25","author":"VT Lan","year":"2012","unstructured":"Lan, V. T., Khang, V. N., Nhu, G. H. & Tuong, H. M. Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure. Reprod. Biomed. Online 25, 254\u2013260. https:\/\/doi.org\/10.1016\/j.rbmo.2012.05.014 (2012).","journal-title":"Reprod. Biomed. Online"},{"key":"36286_CR14","doi-asserted-by":"crossref","unstructured":"European Atosiban Study Group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet. Gynecol. Scand. 80, 413\u2013422 (2001).","DOI":"10.1034\/j.1600-0412.2001.080005413.x"},{"key":"36286_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2174\/1381612825666190329124214","volume":"25","author":"RF Lamont","year":"2019","unstructured":"Lamont, R. F. & J\u00f8rgensen, J. S. Safety and efficacy of tocolytics for the treatment of spontaneous preterm labour. Curr. Pharm. Des. 25, 577\u2013592. https:\/\/doi.org\/10.2174\/1381612825666190329124214 (2019).","journal-title":"Curr. Pharm. Des."},{"key":"36286_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.tjog.2020.07.010","volume":"59","author":"Y Yu","year":"2020","unstructured":"Yu, Y., Yang, Z., Wu, L., Zhu, Y. & Guo, F. Effectiveness and safety of atosiban versus conventional treatment in the management of preterm labor. Taiwan J. Obstet. Gynecol. 59, 682\u2013685. https:\/\/doi.org\/10.1016\/j.tjog.2020.07.010 (2020).","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"36286_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/jhrs.JHRS_7_17","volume":"11","author":"V Mishra","year":"2018","unstructured":"Mishra, V. et al. A prospective case\u2013control trial to evaluate and compare the efficacy and safety of atosiban versus placebo in in vitro Fertilization-embryo transfer program. J. Hum. Reprod. Sci. 11, 155\u2013160. https:\/\/doi.org\/10.4103\/jhrs.JHRS_7_17 (2018).","journal-title":"J. Hum. Reprod. Sci."},{"issue":"213","key":"36286_CR18","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.fertnstert.2006.09.017","volume":"88","author":"P Pierzynski","year":"2007","unstructured":"Pierzynski, P., Reinheimer, T. M. & Kuczynski, W. Oxytocin antagonists may improve infertility treatment. Fertil. Steril. 88(213), e219-222. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.09.017 (2007).","journal-title":"Fertil. Steril."},{"key":"36286_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/s1028-4559(09)60314-4","volume":"48","author":"YL Liang","year":"2009","unstructured":"Liang, Y. L., Kuo, T. C., Hung, K. H., Chen, T. H. & Wu, M. H. Oxytocin antagonist for repeated implantation failure and delay of delivery. Taiwan J. Obstet. Gynecol. 48, 314\u2013316. https:\/\/doi.org\/10.1016\/s1028-4559(09)60314-4 (2009).","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"36286_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tjog.2011.04.003","volume":"50","author":"PY Chou","year":"2011","unstructured":"Chou, P. Y., Wu, M. H., Pan, H. A., Hung, K. H. & Chang, F. M. Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study. Taiwan J. Obstet. Gynecol. 50, 136\u2013140. https:\/\/doi.org\/10.1016\/j.tjog.2011.04.003 (2011).","journal-title":"Taiwan J. Obstet. Gynecol."},{"issue":"654","key":"36286_CR21","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1016\/j.ajog.2021.06.101","volume":"225","author":"W Shi","year":"2021","unstructured":"Shi, W. et al. Blastocyst morphology is associated with the incidence of monozygotic twinning in assisted reproductive technology. Am. J. Obstet. Gynecol. 225(654), e651-654.e616. https:\/\/doi.org\/10.1016\/j.ajog.2021.06.101 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"36286_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-018-0414-2","volume":"16","author":"A Bashiri","year":"2018","unstructured":"Bashiri, A., Halper, K. I. & Orvieto, R. Recurrent Implantation Failure-update overview on etiology, diagnosis, treatment and future directions. Reprod. Biol. Endocrinol. 16, 121. https:\/\/doi.org\/10.1186\/s12958-018-0414-2 (2018).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"36286_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.rbmo.2013.08.011","volume":"28","author":"C Coughlan","year":"2014","unstructured":"Coughlan, C. et al. Recurrent implantation failure: definition and management. Reprod. Biomed. Online 28, 14\u201338. https:\/\/doi.org\/10.1016\/j.rbmo.2013.08.011 (2014).","journal-title":"Reprod. Biomed. Online"},{"key":"36286_CR24","doi-asserted-by":"publisher","first-page":"1053592","DOI":"10.3389\/fendo.2022.1053592","volume":"13","author":"X Zhai","year":"2022","unstructured":"Zhai, X. et al. Efficacy of low-dose hCG on FET cycle in patients with recurrent implantation failure. Front. Endocrinol. (Lausanne) 13, 1053592. https:\/\/doi.org\/10.3389\/fendo.2022.1053592 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"36286_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5653\/cerm.2016.43.4.233","volume":"43","author":"SK Kim","year":"2016","unstructured":"Kim, S. K. et al. Efficacy of oxytocin antagonist infusion in improving in vitro fertilization outcomes on the day of embryo transfer: A meta-analysis. Clin. Exp. Reprod. Med. 43, 233\u2013239. https:\/\/doi.org\/10.5653\/cerm.2016.43.4.233 (2016).","journal-title":"Clin. Exp. Reprod. Med."},{"key":"36286_CR26","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41598-021-81439-6","volume":"11","author":"A Busnelli","year":"2021","unstructured":"Busnelli, A., Somigliana, E., Cirillo, F., Baggiani, A. & Levi-Setti, P. E. Efficacy of therapies and interventions for repeated embryo implantation failure: A systematic review and meta-analysis. Sci. Rep. 11, 1747. https:\/\/doi.org\/10.1038\/s41598-021-81439-6 (2021).","journal-title":"Sci. Rep."},{"key":"36286_CR27","doi-asserted-by":"publisher","first-page":"e0175501","DOI":"10.1371\/journal.pone.0175501","volume":"12","author":"QY Huang","year":"2017","unstructured":"Huang, Q. Y. et al. The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis. PLoS ONE 12, e0175501. https:\/\/doi.org\/10.1371\/journal.pone.0175501 (2017).","journal-title":"PLoS ONE"},{"key":"36286_CR28","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/humrep\/deu058","volume":"29","author":"L Zhu","year":"2014","unstructured":"Zhu, L., Che, H. S., Xiao, L. & Li, Y. P. Uterine peristalsis before embryo transfer affects the chance of clinical pregnancy in fresh and frozen-thawed embryo transfer cycles. Hum. Reprod. 29, 1238\u20131243. https:\/\/doi.org\/10.1093\/humrep\/deu058 (2014).","journal-title":"Hum. Reprod."},{"key":"36286_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1210\/jcem.80.2.7852522","volume":"80","author":"R Chibbar","year":"1995","unstructured":"Chibbar, R., Wong, S., Miller, F. D. & Mitchell, B. F. Estrogen stimulates oxytocin gene expression in human chorio-decidua. J. Clin. Endocrinol. Metab. 80, 567\u2013572. https:\/\/doi.org\/10.1210\/jcem.80.2.7852522 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"36286_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.yhbeh.2004.10.002","volume":"47","author":"A Salonia","year":"2005","unstructured":"Salonia, A. et al. Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm. Behav. 47, 164\u2013169. https:\/\/doi.org\/10.1016\/j.yhbeh.2004.10.002 (2005).","journal-title":"Horm. Behav."},{"key":"36286_CR31","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1471-0528.2000.tb13302.x","volume":"107","author":"R Brouard","year":"2000","unstructured":"Brouard, R., Bossmar, T., Fourni\u00e9-Lloret, D., Chassard, D. & Akerlund, M. Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea. BJOG 107, 614\u2013619. https:\/\/doi.org\/10.1111\/j.1471-0528.2000.tb13302.x (2000).","journal-title":"BJOG"},{"key":"36286_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s43032-019-00088-3","volume":"27","author":"MH Wu","year":"2020","unstructured":"Wu, M. H. et al. Atosiban and pregnancy outcomes following in vitro fertilization treatment for infertile women requiring one, two, or more embryo transfer cycles: A longitudinal cohort study. Reprod. Sci. 27, 853\u2013859. https:\/\/doi.org\/10.1007\/s43032-019-00088-3 (2020).","journal-title":"Reprod. Sci."},{"key":"36286_CR33","doi-asserted-by":"publisher","first-page":"1161707","DOI":"10.3389\/fendo.2023.1161707","volume":"14","author":"R Wang","year":"2023","unstructured":"Wang, R., Huang, H., Tan, Y. & Xia, G. Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis. Front. Endocrinol. (Lausanne) 14, 1161707. https:\/\/doi.org\/10.3389\/fendo.2023.1161707 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"36286_CR34","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1093\/humrep\/deu263","volume":"29","author":"EH Ng","year":"2014","unstructured":"Ng, E. H. et al. A randomized double blind comparison of atosiban in patients undergoing IVF treatment. Hum. Reprod. 29, 2687\u20132694. https:\/\/doi.org\/10.1093\/humrep\/deu263 (2014).","journal-title":"Hum. Reprod."},{"key":"36286_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0301-2115(99)00077-9","volume":"87","author":"C Dorn","year":"1999","unstructured":"Dorn, C. et al. Serum oxytocin concentration during embryo transfer procedure. Eur. J. Obstet. Gynecol. Reprod. Biol. 87, 77\u201380. https:\/\/doi.org\/10.1016\/s0301-2115(99)00077-9 (1999).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"36286_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10815-018-1127-3","volume":"35","author":"S Behbehani","year":"2018","unstructured":"Behbehani, S. et al. Do trained reproductive endocrinologists perform better than their trainees? Comparing clinical pregnancy rates and live birth rates after transfer of single fresh blastocysts. J. Assist. Reprod. Genet. 35, 885\u2013890. https:\/\/doi.org\/10.1007\/s10815-018-1127-3 (2018).","journal-title":"J. Assist. Reprod. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36286-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T14:06:21Z","timestamp":1686146781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36286-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36286"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36286-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"15 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9277"}}